PDCD1 and neoplasm: In addition, tumor cells activate immune checkpoints by promoting the binding of programmed cell death ligand 1 (PD-L1) to programmed cell death 1 (PD-1) on T lymphocytes, which inhibits the antitumor immune function of cytotoxic T lymphocytes and causes immune escape of tumor cells (10).